• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a

tetano

Editor, Senior Moderator
Open Forum Infect Dis. 2017 Oct 7;4(4):ofx212. doi: 10.1093/ofid/ofx212. eCollection 2017 Fall.
[h=1]Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009-2015.[/h] Dwyer DE[SUP]1[/SUP], Lynfield R[SUP]2[/SUP], Losso MH[SUP]3[/SUP], Davey RT[SUP]4[/SUP], Cozzi-Lepri A[SUP]5[/SUP], Wentworth D[SUP]6[/SUP], Uyeki TM[SUP]7[/SUP], Gordin F[SUP]8[/SUP], Angus B[SUP]9[/SUP], Qvist T[SUP]10[/SUP], Emery S[SUP]11[/SUP], Lundgren J[SUP]10[/SUP], Neaton JD[SUP]6[/SUP]; INSIGHT Influenza Study Group.
[h=3]Collaborators (339)[/h]

[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]Background:[/h] Outcome data from prospective follow-up studies comparing infections with different influenza virus types/subtypes are limited.
[h=4]Methods:[/h] Demographic, clinical characteristics and follow-up outcomes for adults with laboratory-confirmed influenza A(H1N1)pdm09, A(H3N2), or B virus infections were compared in 2 prospective cohorts enrolled globally from 2009 through 2015. Logistic regression was used to compare outcomes among influenza virus type/subtypes.
[h=4]Results:[/h] Of 3952 outpatients, 1290 (32.6%) had A(H1N1)pdm09 virus infection, 1857 (47.0%) had A(H3N2), and 805 (20.4%) had influenza B. Of 1398 inpatients, 641 (45.8%) had A(H1N1)pdm09, 532 (38.1%) had A(H3N2), and 225 (16.1%) had influenza B. Outpatients with A(H1N1)pdm09 were younger with fewer comorbidities and were more likely to be hospitalized during the 14-day follow-up (3.3%) than influenza B (2.2%) or A(H3N2) (0.7%; P < .0001). Hospitalized patients with A(H1N1)pdm09 (20.3%) were more likely to be enrolled from intensive care units (ICUs) than those with A(H3N2) (11.3%) or B (9.8%; P < .0001). However, 60-day follow-up of discharged inpatients showed no difference in disease progression (P = .32) or all-cause mortality (P = .30) among influenza types/subtypes. These findings were consistent after covariate adjustment, in sensitivity analyses, and for subgroups defined by age, enrollment location, and comorbidities.
[h=4]Conclusions:[/h] Outpatients infected with influenza A(H1N1)pdm09 or influenza B were more likely to be hospitalized than those with A(H3N2). Hospitalized patients infected with A(H1N1)pdm09 were younger and more likely to have severe disease at study entry (measured by ICU enrollment), but did not have worse 60-day outcomes.


[h=4]KEYWORDS:[/h] follow-up; influenza A(H1N1)pdm09; influenza A(H3N2); influenza B; outcomes

PMID: 29308401 PMCID: PMC5740982 DOI: 10.1093/ofid/ofx212
 
Back
Top Bottom